Cyclopentolate Hydrochloride and Moxetumomab pasudotox
Determining the interaction of Cyclopentolate Hydrochloride and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyclopentolate ophthalmic
Brand name: Cyclogyl, Cylate, AK-Pentolate, Pentolair, Ocu-Pentolate
Synonyms: Cyclopentolate ophthalmic
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cyclopentolate Hydrochloride-Moxetumomab Pasudotox-tdfk
- Cyclopentolate Hydrochloride-Moxetumomab pasudotox-tdfk Intravenous
- Cyclopentolate Hydrochloride-Moxifloxacin
- Cyclopentolate Hydrochloride-Moxifloxacin (Systemic)
- Cyclopentolate Hydrochloride-Moxifloxacin Hydrochloride
- Cyclopentolate Hydrochloride-Moxifloxacin Injection
- Moxetumomab pasudotox-Cyclopentolate ophthalmic
- Moxetumomab pasudotox-Cyclophosphamide
- Moxetumomab pasudotox-Cyclophosphamide Capsules
- Moxetumomab pasudotox-Cyclophosphamide Injection
- Moxetumomab pasudotox-Cyclophosphamide oral and injection
- Moxetumomab pasudotox-Cyclophosphamide Oral, Intravenous